10:42 ET Bid has moved up to 7.55MM @ .18

New Post Public Reply Private Reply Replies (0) Message Board
petemantx Drano #57954
511
10:42 ET Bid has moved up to 7.55MM @ .18
Ask staying same at 1.1938MM @ .185
Snapshot
Charts
News
Options
Analyst Research
Fundamentals
Earnings
Insider Activity

Last Price
$0.180
Today’s Change
+0.0021 (+1.18%)
Bid x Size
0.180 x7,550,000
Ask x Size
0.185 x1,193,800
Day’s Range
0.171 - 0.185
Volume
135,162
OTCQB Real Time Quote Last Trade as of 10:24 AM ET 7/2/19
Extended Hours Quote and Chart ShowHide
Open
0.185
Previous Close
0.1779
52-Week Range
0.070 - 0.64
12/31/18 -7/6/18
Avg Volume (10 days)
270,748
P/E (Trailing 12 mo.)
0.0x
EPS (Trailing 12 mo.)
-0.07364
Next Earnings Date
--
Market Cap
34.2 M
Shares Outstanding
192.1 M
Beta
-0.1
Dividend Yield
--
Dividend
--
Ex-Dividend Date
--
Dividend Payable Date
--

1D
5D
3M
1Y
3Y
5Y

Advanced Chart Historical Quote

Analyst Research
More
No TipRanks analyst consensus available.

Powered by TipRanks
There is no Credit Suisse report available.
There is no Thomson Reuters report available.
There is no Morningstar report available.
There is no SmartConsensus report available.
Technical Research
There is no Market Edge report available.
Technical Analysis
Latest Headlines


Latest Headlines
Press Releases
Commentary & Blogs

Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease
GlobeNewswire 6/6/19 9:30 AM ET
Blogger Sentiment
No TipRanks blogger sentiment available.

Powered by TipRanks
IPIX Company Overview
Innovation Pharmaceuticals Inc., formerly Cellceutix Corporation, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies with oncology, dermatology and antimicrobial applications. The Company owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-cancer compound; Prurisol (KM-133), which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics. The Company's clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Prurisol for the treatment of psoriasis, and Brilacidin for treatments of skin infections, prevention of oral mucositis complicating chemoradiation treatment for cancer, and ulcerative proctitis. The Company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics and inflammatory disease.

Company Contact

Headquarters

100 Cummings Ctr Ste 151b
Beverly, MA 01915-6117

http://www.cellceutix.com/
Quick Links

Add to Watchlist
Historical Quote
View Industry Peers
View My Balances
View My Portfolios
View My Orders

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 25

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 20

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 23

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 23

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 21

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Bob Evans' Protein Mac & Cheese: Practical Power Play

Updated Category News Views 22

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 12

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 19

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 28

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 13

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Audio Solutions Transforming Italian Media Landscape

Updated Category News Views 183

Transforming Audio for Italian Media GEDI, one of Italy's leading media companies, is changing the way newspapers present news to their readers. By incorporating fresh audio content features, they’re responding to the rising demand for audio formats. This shift is not just about keeping up; it’s about creating value in the reader's experience. Introducing Voice...

Continue Reading
Xanadu's Bold Leap in Quantum Computing Secures Major Funding

Updated Category News Views 317

Xanadu Takes a Significant Step Forward in Quantum Technology Xanadu Quantum Technologies Inc., renowned for its innovative work in photonic quantum computing, has made headlines by advancing to Stage B of DARPA's Quantum Benchmarking Initiative. This prestigious progression not only emphasizes Xanadu's prominent role in the future of quantum computing but also secures...

Continue Reading
Fluor Corporation Investors Urged to Act Amid Class Action

Updated Category News Views 238

Fluor Corporation Investors Take Action Amid Legal News In light of recent developments, investors in Fluor Corporation should be aware of their rights and potential actions they can take concerning their investments. The firm, known for its significant contributions to the infrastructure sector, is presently under scrutiny due to allegations regarding undisclosed...

Continue Reading
Lead Real Estate Co., Ltd’s Upcoming Conference Highlights

Updated Category News Views 135

Lead Real Estate Co., Ltd to Participate in Investor Conference Lead Real Estate Co., Ltd (NASDAQ: LRE), a leading Japanese luxury real estate developer, is gearing up for an exciting event as it announces its participation in an important virtual investor conference. The Sidoti Year End Virtual Investor Conference is set to take place on December 10-11, providing...

Continue Reading
Breakthrough FDA Approval of Biocon's New Biosimilars Products

Updated Category News Views 306

FDA Approves Biocon Biologics' New Biosimilars Biocon Biologics Ltd., a prominent player in the biosimilars market and a subsidiary of Biocon Ltd., has reached a significant milestone in its mission to provide affordable biologic therapies. The company recently received approval from the U.S. Food and Drug Administration (FDA) for its new biosimilars, Bosaya™ and...

Continue Reading